⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRO News
Spero Therapeutics, Inc. Common Stock
NATURADE SELECTS REBELUTION AND GROWVANA TO DRIVE U.S. DISTRIBUTION AND ACCELERATE MARKET GROWTH USA - English APAC - English
prnewswire.com
AMZN
COST
SPRO
Noah Kahan & Culture Pop Soda Reimagine Sparkling Black Cherry Flavor in Support of Mental Health
prnewswire.com
AMZN
WMT
SPRO
KRO
Jackson's Accelerates Nationwide Growth as Retailers Lean Into Real-Ingredient, Better-For-You Snacks
prnewswire.com
COST
WMT
TGT
SPRO
KRO
CVS
SE
AMZN
Sparrow Pharmaceuticals Announces First Patient Enrolled in Phase 2b Clinical Trial Evaluating Clofutriben for Difficult-to-Control Type 2 Diabetes
globenewswire.com
SPRO
FDA Officially Confirms Kava is a Food Under Federal Law
accessnewswire.com
SPRO
Spero Announces NDA Resubmission of Tebipenem HBr by GSK to the FDA for the Treatment of Complicated Urinary Tract Infections, Including Pyelonephritis
globenewswire.com
SPRO
Bark Bistro Launches in Sprouts Farmers Market and Expands Retail Footprint
businesswire.com
SPRO
AMZN
CHWY
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
SPRO
Spero Therapeutics Announces Third Quarter 2025 Operating Results and Provides a Business Update
globenewswire.com
SPRO
Spero Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update on November 13, 2025
globenewswire.com
SPRO